IR@PKUHSC  > 北京大学公共卫生学院
学科主题公共卫生
The quality of clinical practice guidelines in China: a systematic assessment
Hu, Jing1,2; Chen, Ru1,2; Wu, Shanshan1; Tang, Jinling3; Leng, Gillian4; Kunnamo, Ilkka5; Yang, Zhirong1,2; Wang, Weiwei1,2; Hua, Xinyang1,2; Zhang, Yuelun1,2; Xie, Yanming6; Zhan, Siyan1,2
关键词AGREE instrument China clinical practice guidelines evidence-based guidelines quality assessment recommendation
刊名JOURNAL OF EVALUATION IN CLINICAL PRACTICE
2013-10-01
DOI10.1111/j.1365-2753.2012.01893.x
19期:5页:961-967
收录类别SCI ; SSCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Health Care Sciences & Services ; Medical Informatics ; Medicine, General & Internal
研究领域[WOS]Health Care Sciences & Services ; Medical Informatics ; General & Internal Medicine
关键词[WOS]MEDICAL LITERATURE ; RECOMMENDATIONS ; APPRAISAL ; CONFLICT ; VALIDITY ; TRIALS
英文摘要

BackgroundClinical guidelines are an important tool for improving service quality, the benefits of guidelines depend on their quality. In China, there has been a great increase in production of guidelines. However, little is known about their quality.

MethodWe identified Chinese guidelines published between 2006 and 2010 by searching three Chinese full-text databases, major Chinese guidelines websites and Google. Three appraisers independently evaluated each guideline by using the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument. Subgroup analyses were performed according to source, title, version, aspect of care and developer of guidelines.

ResultsA total of 327 guidelines were eligible and 57 were excluded for their lacking of any account of the guideline development methodology. Of the 270 guidelines, 77 (28.5%) can be recommended, 6 (2.2%) were evidence-based guidelines. Sixteen (5.9%) guidelines described the methods used to search for evidence, 61 (22.6%) appraised the quality of evidence and 53 (19.6%) graded the strength of recommendations. Two guidelines declared the involvement of methodological experts and none reported considering patients′ values. 29 (10.7%) guidelines received drug company sponsorship but only two declared the views of the funding bodies did not influence the recommendations, 259 (95.9%) didn′t declare the interest conflicts of guideline developers. Guidelines downloaded from Internet and with updated versions yielded higher quality than the rest.

ConclusionsAlthough numerous guidelines were produced in China, the quality was generally low. Focusing on improving the quality of Chinese guidelines, rather than continuing to produce them in great quantity, is urgently needed.

语种英语
WOS记录号WOS:000329285500035
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59646
专题北京大学公共卫生学院
作者单位1.Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100191, Peoples R China
2.Natl Inst Hlth & Clin Excellence, London, England
3.Finnish Med Soc Duodecim, Helsinki, Finland
4.Peking Univ, Evidence Based Med Ctr, Beijing 100191, Peoples R China
5.Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Hong Kong, Peoples R China
6.China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Hu, Jing,Chen, Ru,Wu, Shanshan,et al. The quality of clinical practice guidelines in China: a systematic assessment[J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE,2013,19(5):961-967.
APA Hu, Jing.,Chen, Ru.,Wu, Shanshan.,Tang, Jinling.,Leng, Gillian.,...&Zhan, Siyan.(2013).The quality of clinical practice guidelines in China: a systematic assessment.JOURNAL OF EVALUATION IN CLINICAL PRACTICE,19(5),961-967.
MLA Hu, Jing,et al."The quality of clinical practice guidelines in China: a systematic assessment".JOURNAL OF EVALUATION IN CLINICAL PRACTICE 19.5(2013):961-967.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hu, Jing]的文章
[Chen, Ru]的文章
[Wu, Shanshan]的文章
百度学术
百度学术中相似的文章
[Hu, Jing]的文章
[Chen, Ru]的文章
[Wu, Shanshan]的文章
必应学术
必应学术中相似的文章
[Hu, Jing]的文章
[Chen, Ru]的文章
[Wu, Shanshan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。